2026年11月5日星期四
M
Catatan Universal
Berita Kilat Global
Bangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaTencent says its Hy4 joins 'top-tier' of open-source AI models— 日经 Nikkei AsiaAsian stocks face volatility as Democratic blue wave sweeps US— 日经 Nikkei AsiaChina's slumping state airlines pin hopes on overseas demand like exporters— 日经 Nikkei AsiaDemocrats win control of Congress in sharp rebuke to Trump— 日经 Nikkei AsiaASEAN auto sales rose 13% in Q3 on EV and hybrid demand in key markets— 日经 Nikkei AsiaBangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaTencent says its Hy4 joins 'top-tier' of open-source AI models— 日经 Nikkei AsiaAsian stocks face volatility as Democratic blue wave sweeps US— 日经 Nikkei AsiaChina's slumping state airlines pin hopes on overseas demand like exporters— 日经 Nikkei AsiaDemocrats win control of Congress in sharp rebuke to Trump— 日经 Nikkei AsiaASEAN auto sales rose 13% in Q3 on EV and hybrid demand in key markets— 日经 Nikkei Asia

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

Sumber Nature 医学研究1 hari lalu
Ringkasan konten

Situs ini hanya menyediakan indeks judul dan ringkasan, konten lengkap dan hak cipta sepenuhnya milik penerbit asli, silakan klik tautan asli untuk membaca.

Buka artikel asli
Saluran terkait
Kesehatan
Wilayah terkait
Perspektif global
Bahasa asli
English
Nomor entri
health-05bcbb4d

Comments 0 comments

No comments yet. Be the first.

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial · Catatan Universal